John's mailing address filed with the SEC is 270 E Grand Ave, South San Francisco, CA 94080, USA.
Over the last 16 years, insiders at Portola Pharmaceuticals have traded over 63,947,373$ worth of Portola Pharmaceuticals stock and bought 4,311,442 units worth 137,660,828$ . The most active insiders traders include (Mauritius) Pte Ltd Cairnhi...、James N Topper、Jeffrey W Bird. On average, Portola Pharmaceuticals executives and independent directors trade stock every 43 days with the average trade being worth of 1,543,350$. The most recent stock trade was executed by Hollings Renton on 1 November 2019, trading 5,000 units of PTLA stock currently worth 45,000$.
Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.
Portola Pharmaceuticals executives and other stock owners filed with the SEC include: